DVA DAVITA INC.
Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 927066 · Fiscal year ends 12/31
Financial factors as of 2025-06-30 (2025Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.1%
TTM net income YoY-2.7%
TTM EPS YoY8.0%
Revenue 3-yr CAGR4.2%
Net income 3-yr CAGR0.1%
Margins
Gross margin—
Operating margin15.8%
Net margin6.4%
FCF margin9.8%
EBITDA margin21.1%
Returns
ROE635.3%
ROA4.8%
ROIC (approx.)18.2%
Asset turnover0.76x
Leverage & solvency
Liabilities / assets91.1%
Debt / equity—
Current ratio1.39x
Interest coverage4.00x
Cash quality & payout
Operating cash flow / net income2.23x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue4.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| SG&A expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B |
| Operating income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B |
| Interest expense | $539.92M | $435.20M | $373.95M | $339.25M | $267.05M |
| Pretax income | $1.35B | $1.53B | $1.18B | $966.28M | $1.52B |
| Income tax | $293.11M | $279.66M | $220.12M | $198.09M | $306.73M |
| Net income | $746.80M | $936.34M | $691.53M | $560.40M | $978.45M |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B |
| EPS (basic) | 10.06 | 11.02 | 7.62 | 6.03 | 9.30 |
| EPS (diluted) | 9.84 | 10.73 | 7.42 | 5.85 | 8.90 |
| Weighted avg. shares (diluted) | 75.89M | 87.27M | 93.18M | 95.83M | 109.95M |
| Balance sheet | |||||
| Cash & equivalents | $676.44M | $879.83M | $464.63M | $338.99M | $554.96M |
| Short-term investments | $24.30M | $51.06M | $11.61M | $77.69M | $22.31M |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B |
| Inventory | $160.63M | $134.56M | $143.10M | $109.12M | $107.43M |
| Current assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B |
| PP&E, net | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B |
| Intangibles | $222.12M | $197.43M | $203.22M | $182.69M | $177.69M |
| Total assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B |
| Current liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B |
| Short-term debt | $109.20M | $270.87M | $123.30M | $231.40M | $179.03M |
| Long-term debt | $10.16B | $9.18B | $8.27B | $8.69B | $8.73B |
| Total debt | $10.27B | $9.45B | $8.39B | $8.92B | $8.91B |
| Total liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B |
| Shareholders' equity | -$651.08M | $121.12M | $1.06B | $712.33M | $755.51M |
| Net debt | $9.60B | $8.57B | $7.93B | $8.59B | $8.35B |
| Shares outstanding | 68.55M | 80.54M | 88.82M | 90.41M | 97.29M |
| Cash flow statement | |||||
| Operating cash flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B |
| Capital expenditure | $575.86M | $555.44M | $567.99M | $603.43M | $641.47M |
| Free cash flow | $1.31B | $1.47B | $1.49B | $961.14M | $1.29B |
| Investing cash flow | -$654.95M | -$771.43M | -$771.80M | -$630.35M | -$784.73M |
| Financing cash flow | -$1.37B | -$816.94M | -$1.17B | -$1.12B | -$1.08B |
| Depreciation & amortization | $708.25M | $716.40M | $736.47M | $721.13M | $667.75M |
| Stock-based compensation | $139.95M | $102.79M | $112.38M | $95.43M | $102.21M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Share buybacks | $1.31B | $1.39B | $272.22M | $802.23M | $1.54B |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.